A substance that is being studied as a treatment for advanced prostate cancer and for pain caused by prostate cancer that has spread to the bone. It belongs to the family of drugs called endothelin ETA receptor antagonists.
- yttrium (IH-tree-um)
A rare elemental metal. A radioactive form of yttrium is used in radiation therapy and some types of immunotherapy.
- yttrium Y 90 DOTA-biotin
A compound that contains the radioisotope yttrium Y 90 linked to the chemical biotin. Biotin is a molecule that binds strongly to the chemical streptavidin. Yttrium Y 90 DOTA-biotin will find tumor cells in the body that have been targeted by an antibody linked to streptavidin and kill them. It is being studied together with CC49-streptavidin in the treatment of cancer.
- yttrium Y 90 ibritumomab tiuxetan
An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called IDEC-Y2B8 monoclonal antibody.
- yttrium Y 90 SMT 487
A substance that is being studied as a treatment for cancer. Also called yttrium Y 90-DOTA-tyr3-octreotide.
- yttrium Y 90-DOTA-tyr3-octreotide
A substance that is being studied in the treatment of cancer. Also called yttrium Y 90 SMT 487.